81_FR_19673 81 FR 19608 - Agency Forms Undergoing Paperwork Reduction Act Review

81 FR 19608 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 65 (April 5, 2016)

Page Range19608-19609
FR Document2016-07803

Federal Register, Volume 81 Issue 65 (Tuesday, April 5, 2016)
[Federal Register Volume 81, Number 65 (Tuesday, April 5, 2016)]
[Notices]
[Pages 19608-19609]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-07803]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-15BFV]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    A Study of Viral Persistence in Ebola Virus Disease
    (EVD) Survivors--Existing Information Collection Without an OMB 
Control Number--National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Much progress has been made in the year since the CDC first 
responded to the Ebola outbreak in West Africa, but the agency's 
efforts must continue until there are zero new cases of Ebola virus 
disease (EVD). As the CDC's 2014 Ebola virus response maintains the 
international goal of zero new EVD cases in 2015, the agency must 
intensify its efforts to identify and prevent every

[[Page 19609]]

potential route of human disease transmission and to understand the 
most current community barriers to reaching that final goal.
    Persistence of Ebola Virus (EBOV) in Body Fluids of EVD Survivors 
in Sierra Leone is the first systematic examination of the post-
recovery persistence of EBOV and the risks of transmission from a 
cohort of convalescent Ebola survivors during close or intimate 
contact. It is important to fully understand how long the virus stays 
active in body fluids other than blood in order to target and refine 
public health interventions to arrest the ongoing spread of disease.
    The research study is comprised of three modules based on the body 
fluids to be studied: A pilot module of adult males (semen) and two 
full modules: Module A of adult men and women repeating collections and 
questionnaires every two weeks (semen, vaginal secretions, and saliva, 
tears, sweat, urine, rectal swab), and Module B of lactating adult 
women repeating collections and questionnaires every three days (sweat 
and breast milk).
    Participants for each module will be recruited by trained study 
staff from Ebola treatment units (ETUs) and survivor registries. 
Participants will be followed up at study sites in government 
hospitals.
    Specimens will be tested for EBOV ribonucleic acid (RNA) by reverse 
transcription polymerase chain reaction test (RT-PCR) in Sierra Leone 
at the CDC laboratory facility in Bo. All positive RT-PCR samples will 
be sent to CDC Atlanta for virus isolation. Each body fluid will be 
collected until two negative RT-PCR results are obtained. Participants 
will be followed until all their studied body fluids are negative. They 
will receive tokens of appreciation for their participation at the 
initial visit and again at every subsequent follow-up visit [e.g., 
120,000 Leones (approximately $28 US dollars) and a supply of condoms]. 
For Module A, men and women will be recruited in equal numbers for this 
study until more information on gender effects of viral persistence is 
available. A trained study data manager will collect test results for 
all participants in a laboratory results form.
    Results and analyses are needed to update relevant counseling 
messages and recommendations from the Sierra Leone Ministry of Health, 
World Health Organization, and CDC. The study will provide the most 
current information that is critical to the development of public 
health measures, such as recommendations about sexual activity, 
breastfeeding, and other routine activities and approaches to 
evaluation of survivors to determine whether they can safely resume 
sexual activity. These approaches in turn are expected to reduce the 
risk of Ebola resurgence and mitigate stigma for thousands of 
survivors. The information is likewise critical to reducing the risk 
that Ebola would be introduced in a location that has not previously 
been affected.
    The total burden hours requested for the research study in Sierra 
Leone is 1,836 hours. There are no costs to respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                      No. of          No. of        burden per
         Type of respondent                   Form name             respondents   responses  per     response
                                                                                     respondent       (hours)
----------------------------------------------------------------------------------------------------------------
Data manager.......................  Intake Form................               1             550           20/60
Pilot participants.................  Survivor Questionnaire.....             100               1           30/60
Pilot participants.................  Survivor Follow-up                      100               5           15/60
                                      Questionnaire.
Pilot participants.................  3 & 6 Month Follow up                   100               2           15/60
                                      Questionnaire.
Main study male participants.......  Survivor Questionnaire.....             120               1           30/60
Main study male participants.......  Survivor Follow-up                      120              12           15/60
                                      Questionnaire.
Main study male participants.......  3 & 6 Month Follow                      120               2           15/60
                                      Questionnaire.
Main study female participants.....  Survivor Questionnaire.....             120               1           30/60
Main study female participants.....  Survivor Follow-up                      120               4           15/60
                                      Questionnaire.
Main study female participants.....  3 & 6 Month Follow up                   120               2           15/60
                                      Questionnaire.
Data manager.......................  Laboratory Results Form....               1           4,250           10/60
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07803 Filed 4-4-16; 8:45 am]
 BILLING CODE 4163-18-P



                                                    19608                                    Federal Register / Vol. 81, No. 65 / Tuesday, April 5, 2016 / Notices

                                                    published materials, research, and                                      date, comprehensive database, NPIN                                              The respondent population includes
                                                    trends among the four diseases.                                         plans each year to add up to 400 newly                                        Registered Nurses, Social and
                                                       The NPIN Resources and Services                                      identified organizations and to verify                                        Community Service Managers, Health
                                                    Database contains entries on                                            those organizations currently described                                       Educators, Social and Human Service
                                                    approximately 9,000 organizations and                                   in the NPIN Resources and Services                                            Assistants working within NPIN
                                                    is the most comprehensive listing of                                    Database each year. Organizations with                                        member organizations that provide HIV/
                                                    HIV/AIDS, viral hepatitis, STD, and TB                                  access to the Internet will be given the                                      AIDS, viral hepatitis, STD, and TB
                                                    resources and services available                                        option to complete and submit an                                              prevention, education, testing, and
                                                    throughout the country. The American                                                                                                                  healthcare services.
                                                                                                                            electronic version of the questionnaire
                                                    public can also access the NPIN
                                                                                                                            by visiting the NPIN Web site. Methods                                          This data collection uses no
                                                    Resources and Services database
                                                    through the NPIN Web site. More than                                    to be used to collect the information                                         inferential statistical methods. The data
                                                    1,000,000 unique visitors and more than                                 include online, telephone and email                                           collected is in textual or anecdotal
                                                    3,000,000 page views are recorded                                       survey questionnaires to collect                                              format and will be used for information
                                                    annually.                                                               information from representatives of the                                       purposes.
                                                       To accomplish CDC’s goal of                                          organizations that provide covered                                              There are no costs to respondents
                                                    continuing efforts to maintain an up-to-                                services.                                                                     other than their time.
                                                                                                                           ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                                                    Average
                                                                                                                                                                                                        Number of
                                                                                                                                                                             Number of                                             burden per               Total burden
                                                                     Form name                                           Type of respondents                                                          responses per
                                                                                                                                                                            respondents                                           response (in               (in hours)
                                                                                                                                                                                                        respondent                   hours)

                                                    Initial    Questionnaire              Telephone          Registered nurses, Social and com-                                              400                           1                   15/60                 100
                                                       Script.                                                 munity service managers, and
                                                                                                               Health educators.
                                                    Telephone Verification ......................            Registered nurses, Social and com-                                          6,100                              1                  10/60               1,017
                                                                                                               munity service managers, and
                                                                                                               Health educators Social and
                                                                                                               human service assistants.
                                                    Email Verification ..............................        Registered nurses, Health edu-                                              3,000                              1                  12/60                 600
                                                                                                               cators, and Social and human
                                                                                                               service assistants, social and
                                                                                                               community service managers.

                                                         Total ...........................................   ...........................................................   ........................   ........................   ........................          1,700



                                                    Leroy A. Richardson,                                                       Written comments and suggestions                                           send an email to omb@cdc.gov. Written
                                                    Chief, Information Collection Review Office,                            from the public and affected agencies                                         comments and/or suggestions regarding
                                                    Office of Scientific Integrity, Office of the                           concerning the proposed collection of                                         the items contained in this notice
                                                    Associate Director for Science, Office of the                           information are encouraged. Your                                              should be directed to the Attention:
                                                    Director, Centers for Disease Control and                               comments should address any of the                                            CDC Desk Officer, Office of Management
                                                    Prevention.                                                             following: (a) Evaluate whether the                                           and Budget, Washington, DC 20503 or
                                                    [FR Doc. 2016–07707 Filed 4–4–16; 8:45 am]                              proposed collection of information is                                         by fax to (202) 395–5806. Written
                                                    BILLING CODE 4163–18–P                                                  necessary for the proper performance of                                       comments should be received within 30
                                                                                                                            the functions of the agency, including                                        days of this notice.
                                                                                                                            whether the information will have
                                                    DEPARTMENT OF HEALTH AND                                                practical utility; (b) Evaluate the                                           Proposed Project
                                                    HUMAN SERVICES                                                          accuracy of the agencies estimate of the                                        A Study of Viral Persistence in Ebola
                                                                                                                            burden of the proposed collection of                                          Virus Disease
                                                    Centers for Disease Control and                                         information, including the validity of                                          (EVD) Survivors—Existing
                                                    Prevention                                                              the methodology and assumptions used;                                         Information Collection Without an OMB
                                                                                                                            (c) Enhance the quality, utility, and                                         Control Number—National Center for
                                                    [30Day–16–15BFV]                                                        clarity of the information to be                                              Emerging and Zoonotic Infectious
                                                                                                                            collected; (d) Minimize the burden of                                         Diseases (NCEZID), Centers for Disease
                                                    Agency Forms Undergoing Paperwork                                       the collection of information on those                                        Control and Prevention (CDC).
                                                    Reduction Act Review                                                    who are to respond, including through
                                                                                                                                                                                                          Background and Brief Description
                                                                                                                            the use of appropriate automated,
                                                      The Centers for Disease Control and                                   electronic, mechanical, or other                                                 Much progress has been made in the
                                                    Prevention (CDC) has submitted the                                                                                                                    year since the CDC first responded to
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                                                                                            technological collection techniques or
                                                    following information collection request                                other forms of information technology,                                        the Ebola outbreak in West Africa, but
                                                    to the Office of Management and Budget                                  e.g., permitting electronic submission of                                     the agency’s efforts must continue until
                                                    (OMB) for review and approval in                                        responses; and (e) Assess information                                         there are zero new cases of Ebola virus
                                                    accordance with the Paperwork                                           collection costs.                                                             disease (EVD). As the CDC’s 2014 Ebola
                                                    Reduction Act of 1995. The notice for                                      To request additional information on                                       virus response maintains the
                                                    the proposed information collection is                                  the proposed project or to obtain a copy                                      international goal of zero new EVD
                                                    published to obtain comments from the                                   of the information collection plan and                                        cases in 2015, the agency must intensify
                                                    public and affected agencies.                                           instruments, call (404) 639–7570 or                                           its efforts to identify and prevent every


                                               VerDate Sep<11>2014       17:18 Apr 04, 2016        Jkt 238001      PO 00000        Frm 00060        Fmt 4703        Sfmt 4703       E:\FR\FM\05APN1.SGM              05APN1


                                                                                            Federal Register / Vol. 81, No. 65 / Tuesday, April 5, 2016 / Notices                                                                   19609

                                                    potential route of human disease                                     collections and questionnaires every                               persistence is available. A trained study
                                                    transmission and to understand the                                   three days (sweat and breast milk).                                data manager will collect test results for
                                                    most current community barriers to                                      Participants for each module will be                            all participants in a laboratory results
                                                    reaching that final goal.                                            recruited by trained study staff from                              form.
                                                       Persistence of Ebola Virus (EBOV) in                              Ebola treatment units (ETUs) and                                      Results and analyses are needed to
                                                    Body Fluids of EVD Survivors in Sierra                               survivor registries. Participants will be                          update relevant counseling messages
                                                    Leone is the first systematic                                        followed up at study sites in                                      and recommendations from the Sierra
                                                    examination of the post-recovery                                     government hospitals.                                              Leone Ministry of Health, World Health
                                                                                                                            Specimens will be tested for EBOV                               Organization, and CDC. The study will
                                                    persistence of EBOV and the risks of
                                                                                                                         ribonucleic acid (RNA) by reverse                                  provide the most current information
                                                    transmission from a cohort of
                                                                                                                         transcription polymerase chain reaction                            that is critical to the development of
                                                    convalescent Ebola survivors during
                                                                                                                         test (RT–PCR) in Sierra Leone at the                               public health measures, such as
                                                    close or intimate contact. It is important
                                                                                                                         CDC laboratory facility in Bo. All                                 recommendations about sexual activity,
                                                    to fully understand how long the virus
                                                                                                                         positive RT–PCR samples will be sent to                            breastfeeding, and other routine
                                                    stays active in body fluids other than                               CDC Atlanta for virus isolation. Each                              activities and approaches to evaluation
                                                    blood in order to target and refine                                  body fluid will be collected until two                             of survivors to determine whether they
                                                    public health interventions to arrest the                            negative RT–PCR results are obtained.                              can safely resume sexual activity. These
                                                    ongoing spread of disease.                                           Participants will be followed until all                            approaches in turn are expected to
                                                       The research study is comprised of                                their studied body fluids are negative.                            reduce the risk of Ebola resurgence and
                                                    three modules based on the body fluids                               They will receive tokens of appreciation                           mitigate stigma for thousands of
                                                    to be studied: A pilot module of adult                               for their participation at the initial visit                       survivors. The information is likewise
                                                    males (semen) and two full modules:                                  and again at every subsequent follow-up                            critical to reducing the risk that Ebola
                                                    Module A of adult men and women                                      visit [e.g., 120,000 Leones                                        would be introduced in a location that
                                                    repeating collections and questionnaires                             (approximately $28 US dollars) and a                               has not previously been affected.
                                                    every two weeks (semen, vaginal                                      supply of condoms]. For Module A, men                                 The total burden hours requested for
                                                    secretions, and saliva, tears, sweat,                                and women will be recruited in equal                               the research study in Sierra Leone is
                                                    urine, rectal swab), and Module B of                                 numbers for this study until more                                  1,836 hours. There are no costs to
                                                    lactating adult women repeating                                      information on gender effects of viral                             respondents other than their time.

                                                                                                                        ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                                No. of           Average
                                                                                                                                                                                              No. of          responses        burden per
                                                                      Type of respondent                                                       Form name                                   respondents           per            response
                                                                                                                                                                                                             respondent          (hours)

                                                    Data manager .................................................      Intake Form ....................................................              1                550               20/60
                                                    Pilot participants ..............................................   Survivor Questionnaire ...................................                  100                  1               30/60
                                                    Pilot participants ..............................................   Survivor Follow-up Questionnaire ..................                         100                  5               15/60
                                                    Pilot participants ..............................................   3 & 6 Month Follow up Questionnaire ...........                             100                  2               15/60
                                                    Main study male participants ..........................             Survivor Questionnaire ...................................                  120                  1               30/60
                                                    Main study male participants ..........................             Survivor Follow-up Questionnaire ..................                         120                 12               15/60
                                                    Main study male participants ..........................             3 & 6 Month Follow Questionnaire ................                           120                  2               15/60
                                                    Main study female participants .......................              Survivor Questionnaire ...................................                  120                  1               30/60
                                                    Main study female participants .......................              Survivor Follow-up Questionnaire ..................                         120                  4               15/60
                                                    Main study female participants .......................              3 & 6 Month Follow up Questionnaire ...........                             120                  2               15/60
                                                    Data manager .................................................      Laboratory Results Form ...............................                       1              4,250               10/60



                                                    Leroy A. Richardson,                                                   The meeting will be closed to the                                  Place: National Institutes of Health, 6701
                                                    Chief, Information Collection Review Office,                         public in accordance with the                                      Rockledge Drive, Room 7178, Bethesda, MD
                                                    Office of Scientific Integrity, Office of the                                                                                           20892 (Virtual Meeting).
                                                                                                                         provisions set forth in sections
                                                    Associate Director for Science, Office of the                                                                                             Contact Person: William J. Johnson, Ph.D.,
                                                                                                                         552b(c)(4) and 552b(c)(6), title 5 U.S.C.,                         Scientific Review Officer, Office of Scientific
                                                    Director, Centers for Disease Control and
                                                    Prevention.
                                                                                                                         as amended. The grant applications and                             Review/DERA, National Heart, Lung, and
                                                                                                                         the discussions could disclose                                     Blood Institute, 6701 Rockledge Drive, Room
                                                    [FR Doc. 2016–07803 Filed 4–4–16; 8:45 am]
                                                                                                                         confidential trade secrets or commercial                           7178, Bethesda, MD 20892–7924, 301–435–
                                                    BILLING CODE 4163–18–P                                                                                                                  0725, johnsonwj@nhlbi.nih.gov.
                                                                                                                         property such as patentable material,
                                                                                                                         and personal information concerning                                (Catalogue of Federal Domestic Assistance
                                                                                                                         individuals associated with the grant                              Program Nos. 93.233, National Center for
                                                    DEPARTMENT OF HEALTH AND                                                                                                                Sleep Disorders Research; 93.837, Heart and
                                                    HUMAN SERVICES                                                       applications, the disclosure of which                              Vascular Diseases Research; 93.838, Lung
                                                                                                                         would constitute a clearly unwarranted                             Diseases Research; 93.839, Blood Diseases
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    National Institutes of Health                                        invasion of personal privacy.                                      and Resources Research, National Institutes
                                                                                                                           Name of Committee: National Heart, Lung,                         of Health, HHS)
                                                    National Heart, Lung, and Blood
                                                                                                                         and Blood Institute Special Emphasis Panel,                          Dated: March 30, 2016.
                                                    Institute; Notice of Closed Meeting
                                                                                                                         R13 Conference Grant Application Review.                           Anna Snouffer,
                                                      Pursuant to section 10(d) of the                                     Date: April 28, 2016.                                            Deputy Director, Office of Federal Advisory
                                                    Federal Advisory Committee Act, as                                     Time: 9:00 a.m. to 6:00 p.m.                                     Committee Policy.
                                                    amended (5 U.S.C. App.), notice is                                     Agenda: To review and evaluate grant                             [FR Doc. 2016–07677 Filed 4–4–16; 8:45 am]
                                                    hereby given of the following meeting.                               applications.                                                      BILLING CODE 4140–01–P




                                               VerDate Sep<11>2014       17:18 Apr 04, 2016       Jkt 238001     PO 00000      Frm 00061      Fmt 4703      Sfmt 9990     E:\FR\FM\05APN1.SGM      05APN1



Document Created: 2018-02-07 13:53:20
Document Modified: 2018-02-07 13:53:20
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation81 FR 19608 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR